Related content

Delayed hepatitis B virus reactivation after cessation of preemptive lamivudine in lymphoma patients treated with rituximab plus CHOP

By Dai Ming-Shen   Chao Tsu-Yi   Kao Woei-Yau   Shyu Rong-Yaun   Liu Tan-Mei  

Annals of Hematology, Vol. 83, Iss. 12, 2004-12 ,pp. : 769-774

Springer Publishing Company

Access to resources Recommend Favorite

Possible efficacy of lamivudine treatment to prevent hepatitis B virus reactivation due to rituximab therapy in a patient with non-Hodgkin's lymphoma

By Tsutsumi Y.  

Annals of Hematology, Vol. 83, Iss. 1, 2004-01 ,pp. : 58-60

Springer Publishing Company

Access to resources Recommend Favorite

The effectiveness of lamivudine in preventing hepatitis B viral reactivation in rituximab-containing regimen for lymphoma

By He Yi-Fu  

Annals of Hematology, Vol. 87, Iss. 6, 2008-06 ,pp. : 481-485

Springer Publishing Company

Access to resources Recommend Favorite

Managing hepatitis B reactivation in renal transplant recipients: a 12-year review with emphasis on early detection and early use of lamivudine

By Tsai M.-K.   Lai M.-Y.   Hu R.-H.   Lee C.-J.   Lee P.-H.  

Transplantation Proceedings, Vol. 32, Iss. 7, 2000-11 ,pp. : 1935-1936

Elsevier

Access to resources Recommend Favorite

Successful treatment with lamivudine for reactivated hepatitis B infection following chemotherapy for non-Hodgkin's lymphoma

By Stroffolini T.   Andriani A.   Bibas M.   Barlattani A.  

Annals of Hematology, Vol. 81, Iss. 1, 2002-01 ,pp. : 48-49

Springer Publishing Company

Access to resources Recommend Favorite